A central challenge in the fi eld of metabolic engineering is the effi cient identifi cation of a metabolic pathway genotype that maximizes specifi c productivity over a robust range of process conditions. Here we review current methods for optimizing specifi c productivity of metabolic pathways in living cells. New tools for library generation, computational analysis of pathway sequence-fl ux space, and high-throughput screening and selection techniques are discussed.
INTRODUCTION
Microorganisms have the potential to produce many chemicals of use to society 1, 2 . In some cases, production from heterologous microorganisms is more sustainable than purifying the chemical from natural sources. Examples include harvesting Pacifi c yew trees or Chinese wormwood for taxol 3 or the anti-malarial artemisinin 4 , respectively. Additionally, the ability to create renewable and sustainable biofuels and biochemicals is increasingly attractive given concerns about climate change and peak oil 5 . An organism producing a desired product may not exist, or a given strain may not be suitable for required economical processing conditions. Because of this, reconstructed pathways are oft en implanted into chassis microorganisms 5 . Some of these pathways include those specifi c for biofuels (ethanol 5 , isobutanol 6 , 1-butanol 7 , 1,4-butanediol 8 ), polymer monomers (polylactic acid 9 , isoprene 10 , 3-hydroxypropionic acid 11 ) and pharmaceutically active ingredients (precursors for taxol 3 or opioids 12 ). However, in many cases product toxicity or transport limits end titers, product recovery from aqueous fermentation broths is ineffi cient, or the volumetric productivity is below that required for a cost-eff ective process. Combined, these limitations temper the promise of sustainable replacement of the palette of petrochemicals and naturally extracted specialty chemicals currently in use by society.
In particular, the specifi c productivities of most engineered metabolic pathways are far below that which is needed for industrial production. Some implanted pathways have limited fl ux because of substantial thermodynamic reversibility at key steps 13 . Additionally, pathway enzymes transplanted into heterologous hosts oft en have poor expression because of weak catalytic efficiency 14 , poor protein solubility, or membrane targeting issues 12, 15 . Host-specifi c problems include cofactor accessibility 16 , siphoning of pathway intermediates, intermediate toxicity and post-translational fl ux regulation of key precursors 12, 17, 18 . Furthermore, the performance of a specifi c engineered metabolic pathway may diff er between host strains 19 , media formulations 12 , temperatures and oxygen conditions 20 .
A grand challenge in the fi eld of metabolic engineering is the accurate and effi cient identifi cation of a pathway genotype that maximizes specifi c productivity over a robust range of process conditions. Attempts to improve specific productivity have largely focused on screening individual pathway enzymes for activity or balancing gene expression by testing libraries of elements like promoters and ribosome binding sites (RBS) [21] [22] [23] [24] . Error-prone polymerase chain reaction (PCR) mutagenesis of pathway enzymes has also been used to fi nd activity-improving mutations 17, 18 . However, pathway optimization by total enumeration becomes unwieldy, as balancing activity at multiple nodes leads to a combinatorial explosion. Consider a plasmid-encoded pathway composed of a series of expression elements (e.g. promoters, RBS, terminators) and pathway gene variants (Fig. 1a) . A pathway library comprised of a single enzyme of average length 25 driven by 10 alternative promoter and 10 alternative RBS sequences can be covered by testing 10 2 variants. A library containing the above gene expression genotypes with all possible single non-synonymous mutations to the enzyme now contains 6 × 10 5 variants. Testing the same number of variants using a two-enzyme pathway requires a theoretical coverage of 3.6 × 10 11 variants, which is too large a sequence space to cover under most conditions. Th e combinatorial problem only becomes more acute with more pathway enzymes. To partially circumvent this combinatorial intractability, modular pathway design has been used to partition individual enzymatic steps into reaction groups. Th en, expression of the resulting modules are balanced, not individual enzymes 12, [26] [27] [28] (Fig. 1b) . Alternative ways to explore sequence-fl ux space include computational predictions from small training sets [29] [30] [31] (Fig. 1c) or high-throughput screening or selection techniques [32] [33] [34] [35] [36] (Fig. 1d) . Th e focus of this review is on new technologies that identify highly productive and robust synthetic metabolic pathways. Th is review will not cover continuous evolution 37 , whole-genome engineering 38 or computational pathway design 39 -the interested reader can fi nd excellent reviews on some of these topics elsewhere [40] [41] [42] [43] . We begin by describing pathway evaluation of isogenic cultures. We next describe computational © World Scientific Publishing Co./Imperial College Press INVITED ARTICLE approaches to predict high-performing genotypes with a limited training set of pathway variants. Next, we consider high-throughput methods to assess metabolic pathways, including population-based screens or selections. New enabling techniques for DNA library construction, sequencing and evaluation will be described throughout.
EVALUATION OF ISOGENIC CULTURES
One way to evaluate pathway variants is through the use of isogenic cultures. In a typical set-up, a library containing a combinatorial library of expression elements or enzyme variants is created, and clonal variants are tested individually. Lu et al. optimized a xylose fermentation pathway in Saccharomyces cerevisiae by shuffl ing promoters of various strength in front of each pathway enzyme 44 . Diff erent promoter combinations were made and tested individually for ethanol productivity and enzymatic activity. Solomon et al. tested diff erent expression levels of glucokinase (glk) and galactose permease (galp) to enable glycolytic uptake in Escherichia coli independent of the phosphotransferase system 45 . Carbon fl ux was modulated by controlling expression of glk and galp under control of synthetic constitutive promoters. Juminaga et al. constructed a pathway for L-tyrosine production in E. coli MG1655 by modifying plasmid copy numbers, promoter strength, gene codon usage, and placement of genes in operons 46 . Th e best pathway variant had a volumetric productivity of 55 mg L-tyrosine/L/hr, representing 80% of the theoretical yield. Ajikumar et al. optimized a pathway for overproduction of taxadiene, a key taxol precursor 3 . Th e authors used a modular approach by separating the pathway into two operons, with one containing the methylerythritolphosphate pathway and the other containing genes encoding the downstream terpenoid-producing enzymes. Th e promoter strength in front of each operon was systematically varied and taxadiene product measured. Notably, the taxadiene production landscape was highly non-linear in response to operon expression.
Similar isogenic approaches can be used to engineer key ratedetermining enzymes or transporters in implanted metabolic pathways. Zhang et al. used site-directed mutagenesis of active site residues of the enzymes KivD and LeuA 47 . Fermentations of E. coli harboring pathways with different combinations of KivD/LeuA variants were tested for quantification of desired alcohol products. Leonard et al. generated combinatorial mutations in the downstream enzymes geranylgeranyl diphosphate synthase and levopimaradiene synthase to tune the selectivity and increase the productivity of levopimaradiene production in E. coli 48 
.
The best strain had a maximum volumetric productivity of 7.3 mg levopimaradiene per L per h. Lee et al. improved xylose utilization in S. cerevisiae by directed evolution of xylose isomerase 49 . Aft er three rounds of error-prone PCR and screening they isolated a mutant with a (c) Given a training set of different sequences with a given output, models can be harnessed to predict optimal pathway expression levels. (d) Advanced DNA assembly methods can be used to create unique pathway variants that are then assessed using high-throughput screens or selections.
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61-fold improvement in aerobic growth rate and an eight-fold improvement in ethanol production and xylose consumption. Screening pathway variants is not only limited to enzymes. Young et al. demonstrated the tunability of yeast sugar transporters through a combination of motifbased design and saturation mutagenesis 50 . Th is approach was used to identify xylose-specifi c fungal molecular transporters, which when expressed improved xylose utilization by S. cerevisiae.
COMPUTATIONAL PREDICTIONS USING EMPIRICAL TRAINING SETS
Adjusting the right balance of enzyme specifi c activities within a pathway is crucial as the fi tness cost of protein expression 51 , catabolism of pathway intermediates, and off -product reactions can all lower specifi c productivities. While there have been many admirable attempts to forward engineering biological systems and parts 22, 24, [52] [53] [54] and analytical equations describing pathway fl ux have been formulated 55 , tuning metabolic pathways is largely still an empirical exercise. Because of this, predictive computational models have been used to predict high productivity portions of sequence-fl ux space given sparse fl ux datasets resulting from testing isogenic cultures. Lee et al. used a linear regression model trained on empirical data to relate enzyme expression levels to product titers in a violacein biosynthetic pathway 29 . Th is simple model could accurately predict promoter combinations resulting in the production of violacein or one of the three alternative products. Another approach to computationally model and improve pathway performance is to correlate targeted proteomics and metabolite data. George et al. generated isopentenol pathway variants with diff ering promoters, operon organization, and codon-usage 30 . Th ey then used HPLC and LC-MS to quantify glucose, organic acids, and pathway intermediates and used selected reaction monitoring mass spectrometry to quantify all proteins in their pathway. Spearman rank correlations were calculated from values of protein area and metabolite concentrations. Based on these relationships, individual variants were reconstructed and tested in time-course experiments to test model predictions. While this method may not capture complex regulatory interactions like feedback inhibition, other methods like 13 C metabolic fl ux analysis studies are more than capable of doing so 56, 57 . In one example, Feng et al. tested diff erent xylose reductase, xylitol dehydrogenase and xylulose kinase variants in a yeast xylose pathway and used 13 C metabolic fl ux analysis to determine if the diff erent cofactor requirements of the enzyme variants had any eff ect on growth and/or ethanol production 58 . Th ey found that production of ethanol was unaffected by the cofactor requirements of the xylose pathway. However, the cofactor balanced xylose pathway allowed growth under a wider variety of conditions. Farasat et al. developed a sequence-expression-activity mapping method to fi nd optimal expression conditions with desired activity for a carotenoid biosynthetic pathway 31 . In a fi rst step, an RBS calculator is used to make a library that spans a large range of protein expression space. Next, a subset of the library is tested for activity and used as a training set for a computational model. A new library is then constructed with targeted expression within a narrow window specifi ed by the model. Zelcbuch et al. performed an iterative assembly of three fl uorescent reporters, each with an associated RBS, into an operon 59 . Th is initial search reduced the expression search space for a balanced astaxanthin pathway. In a clever approach, they were able to haplotype the individual non-local RBS sequences included within the operon by sequencing a downstream barcode built using iterative restriction and ligation steps. 33 . Th eir modular design of their pathway allowed quick replacement of RBS and promoter sequences. Oliver et al. improved 2,3-butanediol production in cyanobacteria by using SLIC to swap diff erent RBS sequences in front of each pathway enzyme 34 . Colloms et al. used serine integrase site-specifi c recombination to rank gene order and RBS sites for a more effi cient production of violacein and lycopene 35 . Du et al. used S. cerevisiae native homologous recombination to swap promoters of various expression strength in front of relevant genes 65 . Th is was used to improve xylose and cellobiose utilization pathways. Kim et al. used a similar approach to balance the fl ux of a xylose utilizing pathway for biofuel production 36 . Importantly, the optimal pathway was strongly dependent on both the host genotype but also the sugar composition of the growth medium. Latimer et al. combinatorially tested promoters of the eight-gene pathway for xylose utilization in Saccharomyces cerevisiae 20 . Library plasmids were made with Golden Gate assembly. Similar to results above, they found that the enrichment of specifi c yeast promoters in their library aft er selection was dependent on the number of genes expressed, the culture media conditions, and the cofactor dependence of the enzymes.
ENABLING DNA CONSTRUCTION METHODS

ALTERNATIVE HIGH-THROUGHPUT SCREENING METHODS
Many of the above examples utilized medium-throughput plate-based screening or a growth based selection in order to sort variants. Th ere have been recent developments to employ fl uorescence-activated cell sorting (FACS) or microfl uidic sorting technology in cases without an observable growth phenotype. For example, Wang et al. cultured xylose-consuming strains in droplets and microfl uidic sorting based on the fl uorescence of oxidized extracellular metabolites 66 . Michener et al. utilized FACS to screen improved variants of caff eine demethylase using a designed RNA biosensor 67 . Th e RNA biosensor is a combination of ribozyme and aptamer located in the 3' UTR of a fl uorescent reporter gene. When the aptamer is bound to a desired ligand, the ribozyme misfolds leading to lower RNA cleavage rates and increasing the fl uorescent output. Tang et al. utilized FACS to screen for E. coli clones with enhanced triacetic acid lactone (TAL) production using a an engineered TAL fl uorescent reporter 68 . Jha et al. used a FACS screen to identify E. coli clones with increased enzymatic production of 3,4 dihydroxy benzoate 69 . In these above examples, the limitation is developing a fl uorescent reporter that is coupled to intracellular concentrations of a target metabolite.
POPULATION-BASED MEASUREMENTS
One limitation of high-throughput screening is the inability to haplotype a unique pathway sequence to an output phenotype. Typically, only a few "winners" of the selection are sequenced. Th is is sub-optimal for two reasons. First, the winner variants depend strongly on the exact selection or screening conditions used, and so a selection must be repeated for each change of fermentation condition or host genotype. Th is limitation precludes use of multi-objective optimization (Pareto optimization) techniques into pathway redesign. Recent contributions from the Salis lab show the utility of Pareto optimization to improve translation elongation rates and mRNA stability of a single construct across multiple bacterial species 70, 71 . Secondly, high-throughput methods do not allow coverage of a complete sequence-fl ux space for even moderate-length pathways, and losing crucial genotypic information of the pathway makes it impossible to use the powerful computational analyses and prediction tools that have been demonstrated for low-throughput pathways. We envision population-based measurements that can more thoroughly search sequence-fl ux space and also identify Pareto optimal genotypes that are robust to diff erent processing conditions (Fig. 2) .
Recent advances in deep sequencing technology allow the ability to track tens of thousands of pathway variants in a high throughput screen. Most of such methods rely upon "barcoding" individual cells with a short unique identifi er DNA sequence (Fig. 2a) . A growth selection is performed, and these populations are deep sequenced at the barcode locus. Th e change in frequency of an individual barcode can be related to the fi tness of that unique variant 72, 73 . While in principle such techniques could be used to track individual metabolic pathway variants, most demonstrations have been for studies on evolution. Smith et al. developed a barcode sequencing method (Bar-seq), which they validated by performing growth selections of a mixed culture containing yeast deletion strains 74 . Th e barcode abundance aft er selection was determined for each deletion strain by deep sequencing the entire population. More recently, Levy et al. barcoded 500,000 lineages of Saccharomyces cerevisiae and used a growth selection to track time-dependent changes in fi tness among the population 75 . Chubiz et al. introduced FREQ-Seq, a method to barcode and determine allele frequencies from a mixed population 72 . FREQ-Seq was used to map seven variants of the enzyme Tet(X2), conferring tetracycline resistance, in ten diff erent evolving populations 76 . Frequency analysis of variants within a population can be used to assess if a single variant improves, reduces, or has no eff ect on function. Th is approach has been used for evaluation of yeast translation initiation sites 77 and bacterial promoter strengths 21 by coupling these upstream elements to fl uorescent reporter proteins. Subsequently, populations are sorted by FACS. In fact, massively parallel sequence-function mapping is now commonplace in determining the sequence eff ects on function for proteins 78 . For example, this methodology has been used to improve the affi nity of engineered protein binders to Infl uenza 79 . Th e question remains how to leverage impressive deep sequencing technology to improve implanted metabolic pathways.
In principle, high-throughput sequence-function mapping can be used to determine metabolic pathways supporting higher or lower fl ux, provided that it is coupled to a selectable phenotype like growth. A new approach called FluxScan was recently reported 80 that maps the sequence determinants of fl ux in living cells (Fig. 2b) . First, a selection is designed to allow growth if and only if fl ux is routed through the implanted pathway. A mutational library is then created and transformed into the strain of interest. Aft er a growth selection is performed for 4-10 generations, the entire population is deep sequenced and compared with the population before selection. Th e frequency change of each variant can be calculated and converted to a fl ux value. To demonstrate this method, Klesmith et al. determined the eff ect of fl ux for over 8,000 single-point mutants in a pyrolysis oil catabolic pathway 80 . One designed pathway incorporating 15 benefi cial mutations identifi ed from FluxScan supported a 15-fold improvement in growth rate on levoglucosan, a chief pyrolysis oil constituent.
One signifi cant technical challenge with FluxScan and related deep sequencing approaches is the inability to cover the complete length of metabolic pathways: current long read lengths of the Illumina platform are approximately 300 bp, whereas full operons can exceed 10 kb. One method to escape this limitation is to sequence small contiguous regions of sequence (a gene tile) able to fi t on a single read. Th is "tiling" is then repeated along the length of the entire gene encoding sequence 81 . Other potential solutions to extend deep sequencing include coupling a predefi ned barcode sequence to a given pathway variant using clever DNA construction approaches 32, 59 or to utilize the next generation of long-read, highly accurate haplotype sequencing technologies 82, 83 . Th e ideal outcome of any experiment should be to fi nd Pareto optimal pathway sequences that are robust and transferrable to any process condition. Single isogenic culturing conditions are not suited for this task as each pathway variant would individually have to be tested under each process condition to determine the resulting phenotype. Th erefore, high-throughput population-based measurements are more capable to resolve the fi tness of each sequence variant under each process condition (Fig. 2c) 85 . While these examples highlight gene expression on the genomic scale, the problem also applies to expression and gene variants on the individual pathway level. An example of this is from the aforementioned FluxScan study where the enrichment of individual mutations from the enzyme levoglucosan kinase was strongly dependent on the biophysical properties of the starting enzyme variant from each selection 80 . Being able to measure the pathway phenotype from diff erent expression elements and individual gene variants under diff erent growth conditions should allow the elucidation of pathway sequences that are optimal over a range of diverse conditions and determine why other sequences fail when these conditions change. If implemented, these high-throughput populationbased measurements can help train computational models by providing empirical data and similarly computational models can help reduce the sequence search space for a more targeted population-based screen.
OUTLOOK
In the near future we believe that robust, high performing pathways can be effi ciently identifi ed. New DNA assembly technologies allow for construction of large libraries of pathway variants covering a large range of protein expressions and activities. Th e number of unique pathway variants that can be made far exceeds that which can be accurately validated using existing technology. In this review, we have covered current methods to reduce the search space.
Th ere is no general method that can assess any metabolic pathway, as there are limitations to each of the main approaches. Th ere are two practical limitations that must be surmounted. First, the relationship between gene expression and pathway fl ux is highly non-linear. Second, a specifi c genotype may only support high productivity in a narrow range of process conditions. We suggest that marrying computational modeling with empirical datasets resulting from population-based measurements will allow a more effi cient discovery of Pareto optimal gene encoding, expression, or regulatory sequences.
